News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,791 Results
Type
Article (13643)
Company Profile (108)
Press Release (249040)
Section
Business (87972)
Career Advice (464)
Deals (15333)
Drug Delivery (64)
Drug Development (36554)
Employer Resources (49)
FDA (6270)
Job Trends (6189)
News (150085)
Policy (14014)
Tag
Academia (435)
Alliances (23169)
Alzheimer's disease (371)
Approvals (6280)
Artificial intelligence (73)
Bankruptcy (144)
Best Places to Work (4356)
Breast cancer (64)
Cancer (450)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (61)
Clinical research (30623)
Collaboration (233)
Compensation (96)
COVID-19 (751)
C-suite (76)
Data (448)
Diabetes (64)
Diagnostics (1250)
Drug discovery (45)
Drug pricing (59)
Earnings (31630)
Events (37005)
Executive appointments (263)
FDA (6536)
Funding (153)
Gene therapy (72)
GLP-1 (314)
Government (1272)
Healthcare (3542)
Infectious disease (773)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5848)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3416)
Lung cancer (64)
Manufacturing (113)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9588)
Metabolic disorders (199)
Neuroscience (495)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (548)
Obesity (119)
Opinion (113)
Patents (70)
People (28645)
Pharmaceutical (67)
Phase I (7974)
Phase II (12945)
Phase III (11631)
Pipeline (230)
Policy (47)
Postmarket research (1400)
Preclinical (3181)
Radiopharmaceuticals (116)
Rare diseases (116)
Real estate (2631)
Regulatory (9929)
Research institute (563)
Resumes & cover letters (55)
Southern California (532)
Startups (1625)
United States (5334)
Vaccines (120)
Weight loss (86)
Date
Today (47)
Last 7 days (146)
Last 30 days (713)
Last 365 days (12350)
2025 (641)
2024 (12507)
2023 (14247)
2022 (19556)
2021 (20068)
2020 (19033)
2019 (14886)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (45)
Asia (19937)
Australia (2574)
California (1279)
Canada (719)
China (169)
Colorado (51)
Connecticut (54)
Europe (39016)
Florida (213)
Illinois (145)
Indiana (104)
Japan (59)
Kansas (53)
Maryland (188)
Massachusetts (1109)
Minnesota (70)
New Jersey (528)
New York (358)
North Carolina (317)
Northern California (548)
Pennsylvania (337)
South America (500)
Southern California (532)
Texas (169)
Virginia (49)
Washington State (85)
262,791 Results for "lipella pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lipella Pharmaceuticals Expands its Advisory Board
Lipella Pharmaceuticals Inc. today announced the expansion of its Scientific Advisory Board to include oncology expertise.
April 17, 2024
·
3 min read
Press Releases
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
December 3, 2024
·
6 min read
Press Releases
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
October 30, 2024
·
1 min read
Press Releases
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
November 4, 2024
·
3 min read
News
Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit
October 9, 2024
·
1 min read
Drug Development
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Lipella Pharmaceuticals Inc. announces an abstract publication at the 2024 American Society of Clinical Oncology annual meeting, taking place from May 31 - June 4 in Chicago, IL, and online.
May 29, 2024
·
4 min read
Press Releases
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
November 12, 2024
·
3 min read
Drug Development
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Inc. today announced the successful completion of its first Site Initiation Visit (SIV) for the Phase 2a trial evaluating LP-310 in the treatment of Oral Lichen Planus (OLP).
May 31, 2024
·
5 min read
Press Releases
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
October 15, 2024
·
6 min read
Pharm Country
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) (“Lipella,” “our”, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that its abstract has been accepted for the 2024 American Society of Clinical Oncology (ASCO) meeting on May 31 through June 4 in Chicago, Illinois.
April 5, 2024
·
4 min read
1 of 26,280
Next
